Back to Search
CYNTHIA SIRARD, M.D.
M.D.
Medical Oncology Physician
NPI: 1336271212Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
157248(MA)
Research & Publications (7)
Hillmen trial of alemtuzumab in first-line chronic lymphocytic leukemia still provides valuable information.
PMID 18467736·J Clin Oncol·2008
8-other
Alemtuzumab compared with chlorambucil as first-line therapy for chronic lymphocytic leukemia.
PMID 17984186·J Clin Oncol·2007
3-trial
Smad4 and beta-catenin co-activators functionally interact with lymphoid-enhancing factor to regulate graded expression of Msx2.
PMID 14551209·J Biol Chem·2003
7-preclinical
Carcinogen-induced pancreatic lesions in the mouse: effect of Smad4 and Apc genotypes.
PMID 12096346·Oncogene·2002
7-preclinical
Direct neural fate specification from embryonic stem cells: a primitive mammalian neural stem cell stage acquired through a default mechanism.
PMID 11343645·Neuron·2001
7-preclinical
p53 accumulation, defective cell proliferation, and early embryonic lethality in mice lacking tsg101.
PMID 11172041·Proc Natl Acad Sci U S A·2001
7-preclinical
Targeted disruption in murine cells reveals variable requirement for Smad4 in transforming growth factor beta-related signaling.
PMID 10636910·J Biol Chem·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 500 KENDALL STREET, GENZYME CORPORATION
CAMBRIDGE, MA 02141 - Phone
- (617) 768-6337
Quick Facts
- NPI
- 1336271212
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 7
Are you this provider?
Claim Your Profile